Filing
Spy
Filing
Spy
Home
About
KRTX — Karuna Therapeutics Inc - FilingSpy
KRTX
Karuna Therapeutics Inc
Biopharmaceutical company focused on neurological and psychiatric treatments
CUSIP: 48576A100
Healthcare
US
3 holders
Ownership
Activity
2022 Q3
6 of 14 quarters
Total Value
$270.40M
Total Shares
1.20M
Net Share Change
-159.5K
Activity
3 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$228.10M
1.01M
1.1%
TRIM
-105.2K
(-9.4%)
Viking Global Investors
$228.10M
1.01M shares
TRIM
-105.2K
(-9.4%)
Miller Value Partners
$38.31M
170.3K
2.3%
TRIM
-52.6K
(-23.6%)
Miller Value Partners
$38.31M
170.3K shares
TRIM
-52.6K
(-23.6%)
Patient Capital Management
$3.98M
17.7K
2.0%
TRIM
-1.6K
(-8.3%)
Patient Capital Management
$3.98M
17.7K shares
TRIM
-1.6K
(-8.3%)